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Unraveling the signaling pathways that transmit
information from the cell surface to the nucleus has
been a major accomplishment of modern cell and
molecular biology. The benefit to humans is seen in
the multitude of new therapeutics based on the
illumination of these pathways. Although consider-
able insight has been gained in understanding
homeostatic and pathological signaling in the epider-
mis and other skin compartments, the translation into
therapy has been lacking. This review will outline
advances made in understanding fundamental signal-
ing in several of the most prominent pathways that
control cutaneous development, cell-fate decisions,
and keratinocyte growth and differentiation with the
anticipation that this insight will contribute to new
treatments for troubling skin diseases.
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CALCIUM SIGNALING IN KERATINOCYTES
It has been three decades since awareness of the unique role
of calcium in the regulation of growth and differentiation of
keratinocytes first came to light through studies of cultured
keratinocytes (Hennings et al., 1980). Since that time,
modulation of calcium in vivo and in vitro has been the
major tool used to illuminate the fine structure of keratinocyte
and epidermal biology and has contributed to understanding
the molecular basis of several skin diseases. Beyond
keratinocytes, calcium is increasingly recognized as a central
transmitter of signals in all cells, and calcium signaling is
dynamically controlled during normal cell cycles and in
resting states (Roderick and Cook, 2008; Putney, 2009;
Dupont et al., 2011). The central importance of calcium in
cell physiology is clearly demonstrated by its complex
regulation involving channels, pumps, sensors, binding
proteins, hormones, and receptors, both on the plasma
membrane and intracellular organelles. Furthermore, in both
excitable and nonexcitable cells, there is a constant flux
of calcium exchanged from intracellular compartments and
across the plasma membrane, a process termed calcium
oscillations. Under differing conditions, the cytosolic free
calcium can range from 100nM to 1 mM, and return to
equilibrium may occur in seconds, minutes, or hours
depending on the nature of the stimulus and the requirements
of the functional response. The plasma membrane of most
cells is inhabited by a variety of channels for the influx of
calcium from the extracellular space (Figure 1). Among these
are store-operated calcium channels (SOCE) that activate
influx in response to depletion of intracellular stores. Proteins
known to be associated with this pathway include stromal
interaction molecules (STIMs) that monitor calcium content
of endoplasmic reticulum (ER) stores. Depletion of intra-
cellular stores is sensed by STIMs that then translocate to the
plasma membrane and interact with Orai, the pore-forming
unit of the channel, and TRPC (transient receptor potential C)
to stimulate calcium influx. Additional influx is regulated by
second messenger–operated channels (SMOC) responsive to
diacylglycerol (DAG), receptor-operated channels (ROC)
responsive to hormones, and voltage-gated calcium channels
(VGCC). Calcium influx is also downstream from receptor
tyrosine kinases including EGFR. Adenosine triphosphate
(ATP)-dependent calcium pumps reside on the plasma
membrane and the membranes of intracellular storage sites
such as ER, golgi, and mitochondria. These serve to pump
out excess cytosolic calcium through the plasma mem-
brane (plasma membrane Ca2þ ATPase (PMCA), Naþ /Ca2þ
exchanger (NCX)) or into storage sites sarco (endo)plasmic
recticulum Ca2þ ATPase (SERCA) where calcium remains
bound to high-capacity calcium storage proteins such as
calreticulin of the ER. Of particular importance in calcium
signaling are G-protein–coupled receptors, including the
calcium-sensing receptor (CaR) on the plasma membrane,
that activate membrane-bound phospholipase C (PLC) to
generate inositol phosphates, particularly IP3, that stimulate
receptors on intracellular organelles to release calcium
stores. This elevation of intracellular free calcium is translated
into functional responses through calmodulin and other
downstream effectors. What has become apparent in the
past three decades is that all of these components of calcium
signaling are major regulators of keratinocyte biology.
The calcium gradient inside and out
For almost 25 years, skin biologists have known that the
avascular intact epidermis maintains a calcium gradient that
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is lower in the basal compartment and enriched in granular
cells before a steep drop off in the stratum corneum
(Elias et al., 2002). Disturbance of this gradient by barrier
dysfunction or other means prevents normal keratinocyte
differentiation and accelerates lamellar body secretion.
Although several methods available to early investigators
using fixed tissues confirmed the existence of the gradient,
newer techniques in living tissues suggest that the variation in
the strata arise from differences in intracellular calcium stores
and variations exist within populations in the basal cell
compartment (Celli et al., 2010; Behne et al., 2011). This is
not surprising as it is well documented that graded levels of
extracellular calcium elicit a graded differentiation response
in keratinocytes (Yuspa et al., 1989), buffering of intracellular
calcium prevents terminal differentiation of keratinocytes (Li
et al., 1995a), and the expression of early and late markers of
differentiation are regulated by different intracellular calcium
compartments (Li et al., 1995b). How could these compart-
mental changes be physiologically regulated? Elevation of
extracellular calcium activates several second-messenger
systems. In particular, elevated calcium activates PLC-g1
and PLC-d1 to increase inositol lipids and catalyze the release
of calcium from intracellular stores, acutely increasing
cytosolic calcium (Jaken and Yuspa, 1988; Lee and Yuspa,
1991; Punnonen et al., 1993). What follows is not completely
understood but involves CaR, SOCE, TRPC, and other plasma
membrane cation channels (Mauro et al., 1997; Denda
et al., 2006) to sustain the rise in intracellular calcium and
restore calcium levels in storage sites. Interference with CaR
expression blocks both differentiation and adherens junction
formation in human keratinocytes, and keratinocyte differ-
entiation is defective in CaR-null mice (Tu et al., 2004, 2008).
Downstream effectors of calcium signaling
The observation that keratinocytes from all species tested
proliferate actively in calcium below 0.1mM whereas most
other cells undergo growth arrest or die suggests that an
evolutionary function is conserved. Barrier formation and
specialized cell adhesions are obvious unique functions for
keratinocytes, and calcium is essential for crosslinking
cornified envelopes, desmosome assembly, and creation of
adherens junctions. Furthermore, depletion of ER calcium by
barrier disruption or chemical stress results in rapid secretion
of lamellar bodies in the stratum granulosum to repair the
damage (Celli et al., 2010). The importance of assembling
these structures sequentially and repairing the barrier is clear
and could account for compartmental regulation of calcium
signaling. Consistent with an evolutionary view is the
remarkable clustering of genes essential for terminal differ-
entiation together with calcium-binding S100 proteins on
human chromosome 1q21. Beyond the barrier what are the
downstream effectors of calcium signaling that carry out
the other messages? Activation of calcium-dependent protein
kinase Ca (PKCa) is one effector linked closely to transcrip-
tional regulation of spinous and granular cell proteins through
activator protein-1 activity (Denning et al., 1995; Rutberg
et al., 1997). Furthermore, genes expressed during keratino-
cyte differentiation contain calcium-dependent regulatory
elements (Rothnagel et al., 1993). The calcium–calmodulin
response pathway modifies a number of pathways regulating
cell behavior (Wayman et al., 2011). Among the proteins
activated through calcium–calmodulin is the serine phospha-
tase calcineurin. In keratinocytes and other cells, calcineurin
dephosphorylates NFAT (nuclear factor of activated T cells),
allowing NFAT to enter the nucleus and regulate keratino-
cyte proliferation and stem cell quiescence through p21 in
conjunction with Notch signaling (Dotto, 2011). Recent
studies have implicated TRPV1, TRPV3, and TRPA1 calcium
channels that are highly expressed in keratinocytes to also
contribute to epidermal differentiation and inflammation in
addition to sensory responses (Toth et al., 2009; Cheng et al.,
2010). A compelling role for calcium signaling in keratinocyte
homeostasis comes with the discovery of inactivating muta-
tions in SERCA2 (ATP2A2), the ER calcium ATPase in Darier’s
disease, and mutations in ATP2C1 (SPCA1), the Golgi calcium
ATPase in Hailey–Hailey disease (Sudbrak et al., 2000;
Savignac et al., 2011). In both cases, the mutation results
in calcium depletion in the organelles and disturbances of
skin barrier and keratinocyte adhesion and differentiation. It
is likely that future studies will reveal additional cutaneous
pathology as a consequence of altered calcium homeostasis.
C-ING THE FOREST FOR THE TREES: PLC AND PKC
SIGNALING
Early explorations
The discovery in the early 1980s that PKC was the primary
receptor for tumor-promoting phorbol esters used in mouse
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Figure 1. Integration of the calcium signaling circuitry. The major regulators
of calcium homeostasis in keratinocytes are depicted. Plasma membrane pumps
and channels (PMCA, NCX, and SOCE) regulate flux in and out of the cytosol.
G-protein–coupled receptors (calcium-sensing receptor (CaR) and others not
shown) initiate signals that modify compartmentalized calcium stores (e.g., IP3).
Calcium ATPases on organelles (SERCA, SPCA1) monitor and replenish
intracellular storage sites. Ca2þ , calcium; DAG, diacylglycerol; ER, endoplasmic
reticulum; IP3R, inositol 1,4,5-trisphosphate receptor; NCX, Naþ /Ca2þ
exchanger; NFAT, nuclear factor of activated T cells; PIP2, phosphatidylinositol
4,5-bisphosphate; PKC, protein kinase C; PLC, phospholipase C; PMCA, plasma
membrane Ca2þ ATPase; SERCA, sarco (endo)plasmic recticulum Ca2þ ATPase;
SOCE, store-operated calcium channels; STIM, stromal interaction molecule;
TRPC, transient receptor potential C. The figure is modified from Savignac et al.
(2011) with permission from Elsevier.
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skin chemical carcinogenesis studies captured the imagina-
tion of skin carcinogenesis researchers (Nishizuka, 1984).
This revelation identified the phorbol ester receptor as a
central molecule in PLC-coupled growth factor receptor
signaling and promised to significantly simplify and focus
mechanistic studies on the promotion stage of mouse skin
7,12-dimethylbenz[a]anthracene (DMBA)/12-O-tetradeca-
noyl-phorbol-13-acetate (TPA) chemical carcinogenesis.
From this early perspective, phorbol esters were simply
substituting for chronic mitogenic growth factor stimulation,
and thus directly driving proliferation of keratinocytes.
Almost three decades of intensive research on PLC/PKC
signaling in cutaneous biology have unearthed multiple criss-
crossing pathways involving lipid-derived messengers, phos-
phorylation, and protein interactions, and have expanded
from skin carcinogenesis to epidermal differentiation, wound
healing, and inflammation (Figure 2).
The basic architecture of PLC/PKC signaling consists of
PLC activation via coupling to either G-protein–coupled
receptors or receptor tyrosine kinases, resulting in the
hydrolysis of phosphatidylinositol 4,5-bisphosphate (Suh
et al., 2008). The two second messengers produced by this
cleavage are DAG, which binds C1 domains and activates
PKC, and IP3, which binds to the IP3 receptor and triggers the
release of Ca2þ from intracellular stores. Phorbol esters, such
as TPA, are potent long-lived DAG mimetics that have strong
agonist activity, but at high dose trigger proteasome-
dependent and -independent degradation of PKC resulting
in a type of receptor desensitization (Leontieva and Black,
2004).
Signaling diversification
The discovery and characterization of multiple genes encod-
ing both PLC and PKC have been major driving forces in the
mapping of their interconnected signaling mechanisms. The
PLC gene family has 13 members (b1, b2, b3, b4, g1, g2, d1,
d3, d4, e, Z1, Z2, z) and is more diverse than the nine-
member PKC family (a, b, g, d, e, Z, y, z, i; Parker and
Murray-Rust, 2004; Suh et al., 2008). Each gene family has
subfamilies defined by functional domain composition. These
domains dictate the activation mechanisms and specificity, as
well as the effector functions. For example, the classical,
Ca2þ -responsive PKC isoforms (a, b, g) are responsive to both
DAG/TPA by virtue of their C1 domains, and to Ca2þ by
virtue of their C2 domains. Other PKC subfamilies lack
canonical C2 domains (d, e, Z, y) and C1 domains (z, i)
influencing the cofactor requirements and kinetics of activa-
tion (Lenz et al., 2002). Effector specificity is determined
primarily by selective substrate access dictated by scaffolding
proteins that bind to unique targeting sequences in each PKC
isoform (Kheifets and Mochly-Rosen, 2007). Thus, despite
PKC isoforms having remarkably similar kinase substrate
specificity, they mediate very different functions in the cell
because of unique subcellular localization, cellular substrate
phosphorylation, and activation mechanisms.
The PLC/PKC signaling modules relevant to normal skin
biology involve primarily terminal differentiation. PKCd and
PKCZ are linked to keratinocyte squamous differentiation
(Denning, 2004; Adhikary et al., 2010). For calcium-induced
keratinocyte differentiation, the G-protein–coupled CaR and
PLC-g1 are involved, and mechanisms beyond raising
intracellular calcium may contribute to the pro-differentiation
response and PKC signaling (Tu et al., 2004; Xie and Bikle,
2007). PKC is also linked to differentiation functions of the
pigment-producing melanocyte (Park et al., 1999, 2004).
PKCb is able to phosphorylate and activate tyrosinase, the
rate-limiting enzyme in melanin biosynthesis, and is thus
implicated in melanogenesis.
The heterogeneic PKC signaling landscape has required
cancer biologists to integrate PKC signaling into the larger
cellular and tissue framework to understand how phorbol
esters promote tumor development. In mouse skin chemical
carcinogenesis, initiating H-Ras mutations result in increased
phosphatidylinositol hydrolysis, thus elevating DAG levels
and activating PKCa (Lee and Yuspa, 1991; Denning et al.,
1995). H-Ras activation also elevates Src family kinase
signaling, resulting in inactivation of the pro-apoptotic
PKCd through tyrosine phosphorylation and/or transcrip-
tional silencing (Denning et al., 1993; Geiges et al., 1995;
D’Costa et al., 2006). Chronic TPA treatment results in
selective survival and proliferation of H-Ras mutant kerati-
nocytes, but this occurs in the context of general epidermal
hyperplasia and cytokine release by keratinocytes in response
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Figure 2. Integration of protein kinase C (PKC) signaling circuitry. PKC
isoforms can be activated by the second messenger inputs calcium (Ca2þ )
and diacylglycerol (DAG) generated by the activity of phospholipase C (PLC).
Intracellular calcium activates PKCa, b, and g via their C2 domains, whereas
DAG and 12-O-tetradecanoyl-phorbol-13-acetate (TPA) activate PKCa, b,
g, d, e, Z, and y via C1 domains. Src family kinases can also tyrosine
phosphorylate and alter the expression of PKCd. The outputs of PKC signaling
are isoform dependent as indicated: PKCa (differentiation-associated growth
arrest and cytokine-mediated inflammation), PKCb (melanogenesis), PKCd
(squamous differentiation, growth arrest, and apoptosis), PKCZ (squamous
differentiation and growth arrest), and PKCe (hyperplasia). PIP2, phospha-
tidylinositol 4,5-bisphosphate.
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to TPA. PKCa, PKCe, and NF-kB have been implicated in
this cytokine and inflammatory response, but precisely
how the combined effects of H-Ras activation and chronic
PKC activation result in squamous skin cancers is still
unclear (Cataisson et al., 2005; Wheeler et al., 2005). A
similar scenario exists for UV skin carcinogenesis as UV
elevates DAG levels, pro-apoptotic PKCd expression is
repressed, and chronic activation of PKCe promotes regen-
erative hyperplasia (Punnonen and Yuspa, 1992; Jansen et al.,
2001; Aziz et al., 2007). One reasonable model for the role
of PKC isoforms in skin carcinogenesis is selective activa-
tion of PKCa driving inflammation, whereas PKCe drives
cell proliferation. In association, inactivation/repression
of pro-apoptotic PKCd promotes cell survival. This model
is supported by studies in transgenic mice in which PKCe
transgenic mice are highly susceptible to both chemical
and UV skin carcinogenesis, whereas PKCd mice are resistant
to skin carcinogenesis (Reddig et al., 1999, 2000; Jansen
et al., 2001).
Nonstandard keratinocyte responses
Several of the fundamental signaling molecules related to
PLC/PKC signaling function very differently in epidermal
keratinocytes compared with most other cell types. Central
among these is calcium, which is abbreviated as ‘‘C’’ in PKC
despite most PKC isoforms lacking a canonical C2 domain
and being calcium independent. As discussed previously,
most cells bathed in serum in vivo or grown in tissue culture
proliferate normally in 41mM calcium. In contrast, epider-
mal keratinocytes proliferate well in o0.1mM calcium and
are induced to undergo squamous differentiation by 41mM
Ca2þ in association with PLC/PKC activation (Hennings
et al., 1980; Denning et al., 1995). Keratinocytes also express
PKCZ, a PKC isoform unique to squamous differentiation
tissues (Kashiwagi et al., 2002). The function of the PKC
effector NF-kB in keratinocytes is also unusual. NF-kB is pro-
survival and thus promotes cancer development in most cell
types; however, the NF-kB upstream activating kinase IKKa
promotes keratinocyte differentiation, and blockade of NF-kB
activation with a dominant/negative IkB is a potent oncogene
in human keratinocytes (Hu et al., 2001; Dajee et al., 2003).
The signaling responsible for these unusual keratinocyte
responses is still enigmatic, but is an area of active
investigation.
Therapeutics
Despite the complexity of PLC/PKC signaling and lack of
isoform-selective small-molecule activators/inhibitors, the
diverse and significant effects of PLC/PKC modulation on
skin biology have attracted much interest from drug devel-
opers. Ingenol-3-angelate (ingenol mebutate, PEP005), which
activates PKCd and has unusually deep tissue penetration, has
promising clinical activity against premalignant actinic
keratosis (Hampson et al., 2005; Siller et al., 2009; Li et al.,
2010). Another area of potential therapeutics is inhibition of
PKCb to block pigmentation. Increased knowledge of PKC
activation mechanisms, effector specifics, and the nonstan-
dard keratinocyte signaling responses will undoubtedly
continue to challenge the imagination of investigative
dermatologists for at least another 25 years.
THE PROFOUND INFLUENCE OF EGFR SIGNALING IN
CUTANEOUS BIOLOGY
Overview of the EGFR signaling pathway and relevance in skin
biology
The EGFR is expressed almost ubiquitously with the excep-
tion of mature hematopoietic cells. EGFR is a member of a
family of four receptors namely ERBB1 or EGFR, ERBB2,
ERBB3, and ERBB4. Ligand binding triggers receptor dimer-
ization followed by transphosphorylation on multiple tyr-
osine residues (Schulze et al., 2005). Homo- or heterodimer
receptor partners interact with a growing family of ligands
such as EGF, transforming growth factor-a (TGF-a), heparin-
binding EGF-like growth factor (HBEGF), amphiregulin
(AREG), betacellulin (BTC), epiregulin (EREG), neuregulins
1–4 (NRG1-4), and epigen (EPGN) (Figure 3). Ligands are
normally expressed as transmembrane precursors and act in
autocrine, paracrine, and juxtacrine manner to influence
EGFR activation. EGFR ligand precursors normally undergo
ectodomain shedding by the action of membrane proteases of
the ADAM family and activate the receptors (Edwards et al.,
2008). The discovery of the ‘‘triple membrane passing
signal,’’ where a stimulus would trigger ADAM proteases
activity and transactivate EGFR, revealed multiple ways of
regulating EGFR activity through external stimuli (Liebmann,
2011). Mouse models with aberrant expression of receptors
or ligands show a profound effect on skin biology. For
example, loss of transforming growth factor-a affects hair
follicle structure, whereas the overexpression of the same
ligand or overexpression of the isoform ERBB2 causes skin
hyperplasia and enhanced tumor formation. In contrast,
deletion of epiregulin or overexpression of amphiregulin
causes inflammatory skin diseases with features of atopic
dermatitis and psoriasis, respectively (Schneider et al., 2008).
Mice with an EGFR-dominant negative mutation targeted to
the epidermis have curled whiskers and short hair that
become progressively sparse (Murillas et al., 1995), whereas
a defect in hair follicle differentiation and maturation is also
evident in skin grafts from EGFR-ablated neonatal skin on
nude mice (Hansen et al., 1997).
Downstream effectors of EGFR signaling
After the transphosphorylation of the receptor on several
tyrosine residues, a number of adaptor proteins are recruited
to the intracellular domain of EGFR. These include GRB2
(growth factor receptor-bound 2) coupled to the guanine
nucleotide–releasing factor SOS (Son of Sevenless). These
protein interactions bring SOS in close proximity to Ras,
allowing for Ras activation. Activated Ras recruits c-Raf to the
cell membrane where it phosphorylates and activates
mitogen activated protein kinase kinase1/2 (MEK1/2), even-
tually leading to the activation of extracellular signal–regu-
lated kinase 1 and 2 (ERK1/2) (Oda et al., 2005). The EGFR/
ERK pathway mediates both the pro-survival and proliferative
programs of keratinocytes (Dumesic et al., 2009). ERK1/2 and
c-Jun N-terminal kinases 1/2 are activated within the first few
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minutes of EGFR ligand binding and mediate expression of
immediate early genes involved in keratinocyte proliferation.
Within the early genes, c-jun is an important regulator of the
EGFR pathway. c-Jun mutant primary keratinocytes exhibit a
severe proliferation and differentiation defect, and EGFR
expression is downmodulated (Zenz et al., 2003). In the
absence of fully functional EGFR, c-Jun expression and c-Jun-
dependent transcription are reduced in cultured keratinocytes
and in skin (Mascia et al., 2010).
EGFR recruits directly through tyrosine phosphorylation of
phosphatidylinositol 30-OH kinase. The phospholipid pro-
ducts of phosphatidylinositol 30-OH kinase activate phos-
phoinositide-dependent kinase 1 and recruit AKT to the
plasma membrane. This sequence of events occurs upon
UVB irradiation of keratinocytes and reactive oxygen
species–mediated EGFR transactivation. Pretreatment of
keratinocytes with EGFR inhibitors abolishes UV-induced
AKT activation–phosphorylation, and increases UV-induced
apoptosis (Wang et al., 2003). PLC-g1 associates with and is
phosphorylated by the EGFR tyrosine kinase, leading to
mitogenic and differentiation responses involving PKC
modification. For example, calcium-induced transforming
growth factor-a inhibits PKCd activity via EGFR-dependent
tyrosine phosphorylation, and this modification is associated
with reduced keratinocyte terminal differentiation (Denning
et al., 1996).
Deactivation of EGFR signaling
The multifunctional nature of EGFR activation requires
multiple mechanisms of attenuating or eliminating the initial
signal. Multiple negative feedback loops are placed in action,
including changes in compartmentalization, posttranslational
modification, and transcriptional upregulation of negative
regulators. Receptor internalization coupled to degradation is
a highly effective process that attenuates EGFR signaling by
targeting surface receptors for degradation in lysosomes
(Sorkin and Goh, 2008). Another general mechanism of
signal attenuation is represented by tyrosine phosphatases at
the receptor level (Xu et al., 2005) and dual-specificity
phosphatases at the mitogen-activated protein kinase level
(Zhang et al., 2010). A second wave of modulators becomes
available upon transcriptional activation. For example, MIG6
(mitogen-inducible gene-6) is a newly synthesized negative
regulator that functions directly on the receptor (Ferby et al.,
2006).
EGFR is a major regulator of skin immunohomeostasis
Although considerable work has focused on the role of the
EGFR on epidermal and hair follicle development, keratino-
cyte proliferation, and survival, recent studies have revealed
that EGFR is a major contributor to immune homeostasis in
the skin. Pharmacologic inhibition of EGFR regulates two
subsets of cytokines and chemokines in keratinocytes at the
transcriptional and posttranscriptional level. Although the
transcription of GM-CSF and CXCL8 is positively regulated
with EGFR stimulation, the absence of a functional EGFR/ERK
pathway enhances the expression of CCL2 (chemokine (C-C
motif) ligand 2), CCL5, and CXCL10 (chemokine (C-X-C
motif) ligand 10), and decreases the expression of CXCL8 and
GM-CSF both in vitro and in vivo (Mascia et al., 2003, 2010;
Pastore et al., 2005). EGFR blockade is also associated with
increased levels of CCL17 and major histocompatibility
complex class I and II (Komine et al., 2005; Pollack et al.,
2011) in the skin, and CXCL9, CCL3, and CCL11 in cervical
cancer cell lines (Woodworth et al., 2005). The strongest
evidence that EGFR signaling regulates inflammatory re-
sponses in human skin is provided by the adverse effects of
the chemotherapeutic agents that target EGFR, such as
Cetuximab, Panitumumab, Gefitinib, and Erlotinib. Within
the first 2 weeks of treatment, the majority of cancer patients
who receive anti-EGFR drugs develop a papulopustular rash
associated with dry skin and pruritus (Lacouture, 2006). The
presence of the rash is a general indicator that the drug hits its
target both in the skin and in the tumor. Some authors
speculate that there is an association between the rash grade
and the overall survival of the patients (Perez-Soler and Saltz,
2005). Interestingly, the increase of homeostatic chemokines
CCL27 and CXCL14 after treatment of cell lines with anti-
EGFR drugs is associated with a possible role of these
chemokines in the antitumor immune response (Pivarcsi
et al., 2007; Ozawa et al., 2009). These observations need to
be corroborated in proper tumor models but underline the
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Figure 3. Integration of EGFR signaling circuitry. EGFR and other ERBB
receptors dimerize after engagement with their ligands, activating multiple
signaling cascades through recruitment of adaptor and signaling proteins to
the intracellular portion of the receptor. Phospholipase C-g (PLC-g) activity
triggers the activation or downmodulation of protein kinase C (PKC) isoforms
and increases intracellular calcium, leading to the regulation and expression
of proteins that control differentiation. Phosphoinositol 30-OH kinase (PI3K)
promotes survival responses through AKT activity. Activation of Ras regulates
c-Jun N-terminal kinase 1/2 (JNK1/2) and extracellular signal–regulated kinase
1 and 2 (ERK1/2) mitogen-activated protein kinase (MAPK) activity causing
changes in gene transcription and mRNA stability. As a consequence,
cell-cycle progression and inflammatory responses are fine-tuned by EGFR
activity. Ca2þ , calcium; CCL2, chemokine (C-C motif) ligand 2; CXCL10,
chemokine (C-X-C motif) ligand 10; DAG, diacylglycerol; grb2, growth factor
receptor-bound 2; HB-EGF, heparin-binding EGF-like growth factor; PIP2,
phosphatidylinositol 4,5-bisphosphate; Sos, Son of Sevenless; TGF-a,
transforming growth factor-a.
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role of EGFR in regulating the expression of inflammatory
mediators during skin carcinogenesis. Recent evidence shows
that oncogenic Ras-driven expression of CXCR2 ligands
depends on EGFR expression and acts in an autocrine
manner to enhance migration of transformed keratinocytes
(Cataisson et al., 2009). These data collectively define the
profound influence of EGFR signaling on cutaneous biology.
THE MULTIPLE CONTRIBUTIONS OF NOTCH
SIGNALING IN SKIN BIOLOGY
Overview of the Notch signaling pathway and relevance in skin
biology
The Notch pathway constitutes a short-range communication
channel involved in many fundamental aspects of multicellular
life: proliferation, stem cells and niche maintenance, cell-fate
acquisition, differentiation, and cell death. Mammals express
multiple ligands and four Notch receptors but only one
nuclear signal mediator, the DNA-binding protein RBPjk
(Kopan and Ilagan, 2009) (Figure 4). Signaling is initiated
when ligand binding to the receptor induces unfolding of a
juxtamembrane-negative control region, which allows access
to proteases. Proteolysis by an ADAM sheds the extracellular
domain; g-secretase then cleaves Notch within its transmem-
brane domain to release the intracellular domain (Notch
intracellular domain or Notch intra). Notch intracellular
domain translocates to the nucleus, binds to RBPjk, and helps
recruit one of three adaptor proteins (MAML1–3; Kopan and
Ilagan, 2009). Thus, every cleaved Notch molecule generates
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Figure 4. Integration of Notch signaling circuitry. The Notch pathway generates a short-range communication channel utilized throughout skin development
and elsewhere in the adult to regulate multiple cellular processes (e.g., proliferation, stem cell and stem cell niche maintenance, cell-fate specification,
differentiation, and cell death). Notch signals in a unique mechanism mediated by proteolysis and without any secondary messengers. Posttranslational
modifications and trafficking of the ligands and receptors can regulate the amplitude and timing of Notch activity. (1–2) Receptor maturation. Upon translation, the
Notch protein is fucosylated by the Pofut1 (protein O-fucosyltransferase 1). The fucose can be extended by the glycosyltransferase activity of Fringe. This affects
the ability of specific ligands to activate Notch (see below). During exocytosis, the Notch receptor is cleaved by PC5, a protein convertase, at site 1 (S1). At the cell
surface, Notch is a heterodimer (HD) held together by noncovalent interactions within the HD domain, which, together with three Lin/Notch repeats (LNRs),
forms the negative regulatory region (NRR). (2) The steady-state levels of the Notch receptor at the cell surface are regulated by several proteins, many of which
are E3 ubiquitin ligases (Dtx, Nedd4). After recycling, inappropriate receptor activation within endosomes can occur in the absence of ligand binding
(Notch intracellular domain (NICD)*). The ESCRT (endosomal sorting complex required for transport) complex proteins are involved in Notch downregulation,
and mutations in this complex may contribute to pathogenesis in different cellular contexts. (3) Ligand maturation. Notch ligands are also type I transmembrane
proteins. The two major classes of ligands are Delta and Jagged (Serrate in Drosophila), the latter containing a cysteine-rich domain. To signal, ligands
must undergo ubiquitinylation by E3 ubiquitin ligases Neur and Mib, which trigger Epsin-mediated endocytosis, and an undefined modification produces an
active ligand, which recycles to the cell surface in a Rab11-dependent process. Current models explaining the nature of ligand modification include ligand
clustering, posttranslational modifications, and/or recycling into specific membrane domains. (4–6) Activation. Productive receptor–ligand interactions occur
between neighboring cells (in TRANS), whereas negative interactions occur between receptor–ligand proteins coexpressed in the same cell (in CIS). Fringe-
modified Notch1 receptors favor Delta binding (shown). Ligand endocytosis is thought to generate sufficient force to unfold the NRR, exposing Notch to cleavage
at site S2 by ADAM10 metalloproteases. The membrane-anchored NEXT (Notch extracellular truncation) fragment is recognized by g-secretase, an enzymatic
complex composed of presenilin (PS), nicastrin (NCT), PS enhancer 2 (PEN2), and anterior pharynx-defective 1 (APH1). g-Secretase then cleaves the Notch
transmembrane domain sequentially starting near the cytosolic surface (sites S3 and S4) to release the NICD and Nb peptides, respectively. (5) In the absence
of NICD, the DNA-binding protein CSL associates with ubiquitous corepressor (Co-R) proteins, histone deacetylases (HDACs) and Sirtuin 1 (Sirt1), to repress
transcription of target genes. NICD binding to CSL recruits the adaptor protein Mastermind (MAM), which recruits the mediator complex and assembles an
active transcription complex on target promoters. (6) During the transcriptional activation process, NICD is phosphorylated on its proline, glutamate, serine,
threonine (PEST)-rich domain by kinases such as CDK8 and targeted for proteasomal degradation by E3 ubiquitin ligases such as Sel10/Fbw7. This terminates the
Notch signal and resets the cell for the next round of signaling. This figure is reproduced from Ilagan and Kopan (2007) with permission from Elsevier.
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one signaling unit. In addition to this generalized model,
evidence is mounting that RBPjk-independent activities of
Notch can also contribute to vertebrate skin development
(Rangarajan et al., 2001; Demehri et al., 2008), but the
biochemical details of this signaling arm are yet to be
uncovered.
Ignoring Notch function in the innate immune system, the
Notch pathway participates in the development, mainte-
nance, or function of at least four skin compartments: the
melanocytes (Moriyama et al., 2006; Kumano et al., 2008),
the dermal papilla fibroblast (Hu et al., 2010), the epidermal
keratinocyte (Rangarajan et al., 2001; Blanpain et al., 2006;
Demehri et al., 2008; Dumortier et al., 2010), and the hair
follicle keratinocyte (Pan et al., 2004; Lee et al., 2008;
Moriyama et al., 2008). Cell-autonomous Notch signals (i.e.,
affecting the cell receiving the Notch signal) control
melanocyte stem cell homeostasis, but Notch contributes to
the melanocyte niche in the hair follicle also by regulating Kit
ligand production (Lee et al., 2007), which is non-cell
autonomous (i.e., by regulating diffusible or surface mole-
cules affecting neighboring cells). Genetic loss-of-function
analysis established that Notch does not contribute to the
positional patterning of skin appendages, but once their
position has been determined via Wnt, fibroblast growth
factor (FGF), bone morphogenetic protein (BMP), and
enhanced ectodysplasin-A receptor (Edar) signaling, Notch
contributes in several ways to the normal formation of nails,
hair follicles, feathers, and scales. First, it is active in dermal
papilla cells upstream of Wnt5A (Hu et al., 2010). Second,
Notch receptors have an important late role in maintenance
of all the cell layers within the appendages. This function is
both cell autonomous (Pan et al., 2004) and non-cell
autonomous (Lin et al., 2000), including feedback interac-
tion between the follicular keratinocyte, the dermal
papilla, and the melanocyte (Lee et al., 2007). Third,
Notch-dependent signals either attract or support adipo-
cytes as the dermis underneath the Notch-deficient epidermis
is depleted of lipid droplets, and sebaceous glands form
but do not mature (Pan et al., 2004). Fourth, in epidermal
keratinocytes, Notch signaling promotes exit from the
basal layer and initiation of differentiation (Rangarajan
et al., 2001; Blanpain et al., 2006; Demehri et al., 2008;
Dumortier et al., 2010). Finally, Notch may contribute to the
regulation of the stem cell niche in the human epidermis
(Lowell et al., 2000).
Notch signaling in skin carcinogenesis
Loss of Notch1 in the epidermis enhances carcinogenesis
(Nicolas et al., 2003). This is due to a feed-forward, non-cell-
autonomous loop between Notch-deficient keratinocytes, the
dermal fibroblast population, and the inflammatory infiltrate
(Demehri et al., 2009). The resulting fibroplasia, inflamma-
tion, and angiogenesis promote papilloma formation in both
Notch-depleted and Notch-expressing keratinocytes within
this environment. In this model, progression to cancer is
accelerated when Notch1 protein is lost (Demehri et al.,
2009). Interestingly, skin keratinocytes are exquisitely sensi-
tive to the dose of Notch signals. Spontaneous tumor latency
decreases as the dose of Notch alleles decreases (Demehri
et al., 2009). Mice lacking alleles of three out of four proteins
comprising the g-secretase complex (Pen2, Psen1, and Ncstn)
develop spontaneous tumors as well (Xia et al., 2001; Li
et al., 2007). Importantly, humans with nonsense mutations
in PEN2 (two families), PSEN1 (one family) and NCSTN (three
families; Wang et al., 2010) develop hidradenitis suppurativa
or acne inversa (Online Mendelian Inheritance in Man
(OMIM) 11405761). Retroactive analysis of the Swedish
national cancer registries identified a 50% increased risk for
non-melanoma skin cancer in families with hidradenitis
suppurativa (Lapins et al., 2001). These findings dovetail
nicely with recent reports that the g-secretase inhibitor
semagacestat, designed to reduce Notch signaling, was
withdrawn from clinical testing because of elevated inci-
dence of skin cancer. Given that heterozygosity of g-secretase
components is symptomatic in humans and mice, even
‘‘Notch-sparing’’ drugs must be carefully evaluated in clinical
trials for skin differentiation defects and the subsequent
inflammatory cascade.
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